Reversible Suppression of Cyclooxygenase 2 (COX-2) Expression In Vivo by Inducible RNA Interference

• Anne K. Zaiss,

  Affiliations Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America, Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Johannes Zuber,

  Current address: Research Institute of Molecular Pathology (IMP), Vienna, Austria

  Affiliation Cold Spring Harbor Laboratory and Howard Hughes Medical Institute, New York, New York, United States of America

  ⨯
• Chun Chu,

  Affiliations Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America, Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Hidevaldo B. Machado,

  Affiliations Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America, Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Jing Jiao,

  Affiliations Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America, Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Arthur B. Catapang,

  Affiliations Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America, Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Tomo-o Ishikawa,

  Affiliations Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America, Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Jose S. Gil,

  Affiliations Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America, Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Scott W. Lowe,

  Affiliation Cold Spring Harbor Laboratory and Howard Hughes Medical Institute, New York, New York, United States of America

  ⨯
• Harvey R. Herschman

  * E-mail: hherschman@mednet.ucla.edu

  Current address: Memorial Sloan-Kettering Cancer Center, New York, New York, New York, United States of America

  Affiliations Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America, Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯